文献速递眼底病与葡萄膜炎

Caveolin-1通过促进细胞衰老阻断视网膜下纤维化

Caveolin-1 Promotes Cellular Senescence in Exchange for Blocking Subretinal Fibrosis in Age-Related Macular Degeneration.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2020-01-01

在激光诱导的视网膜下纤维化小鼠模型中,caveolin-1肽段cavtratin可显著减小纤维化体积并改善RPE细胞收缩,但同时降低细胞活力并增加衰老标志物。研究提示caveolin-1在阻断RPE上皮-间质转化的同时促进细胞衰老,可能影响地图样萎缩进展。

要点

  • cavtratin注射眼视网膜下纤维化体积显著小于对照眼(P=0.0062)和Cav-1-/-小鼠(P=0.0095)。
  • cavtratin改善野生型(P=0.04)和Cav-1-/-小鼠(P=0.01)原代RPE细胞收缩。
  • cavtratin降低RPE细胞活力并增加衰老相关β-半乳糖苷酶阳性细胞,但不影响凋亡或活性氧生成。

核心结论

  • caveolin-1增强表达可阻断RPE上皮-间质转化并减少小鼠视网膜下纤维化。
  • caveolin-1在阻断纤维化的同时促进RPE细胞衰老,可能影响AMD地图样萎缩进展。

研究设计与样本

  • 使用野生型和Caveolin-1敲除(Cav-1-/-)小鼠,给予或不给予cavtratin(caveolin-1细胞穿透肽)处理。
  • 检测激光诱导的视网膜下纤维化和RPE细胞收缩,并在人RPE组织、老年小鼠眼及原代人RPE细胞中检测衰老标志物p16INK4a。

主要发现

  • cavtratin注射的野生型小鼠眼视网膜下纤维化体积显著小于野生型对照眼(P=0.0062)和Cav-1-/-小鼠眼(P=0.0095)。
  • cavtratin处理显著改善野生型(P=0.04)和Cav-1-/-小鼠(P=0.01)原代RPE细胞收缩。
  • 地图样萎缩患者RPE中p16INK4a表达高于无地图样萎缩患者。
  • p16INK4a在18月龄野生型小鼠眼表达,而在2月龄小鼠眼不表达。
  • p16INK4a与I型胶原抗体在视网膜下纤维化中共定位。

临床怎么用

  • caveolin-1通路可能作为阻断视网膜下纤维化的干预靶点,但需权衡其促衰老效应。
  • RPE细胞衰老标志物p16INK4a或可用于评估AMD地图样萎缩相关进展风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine whether caveolin-1 (i) prevents epithelial-mesenchymal transition in the RPE and laser-induced subretinal fibrosis and (ii) promotes or inhibits cellular senescence in the RPE. METHODS: We examined laser-induced subretinal fibrosis and RPE cell contraction in wild-type and Caveolin-1 knockout (Cav-1-/-) mice treated with or without cavtratin, a cell-permeable peptide of caveolin-1. The senescence marker p16INK4a was measured in RPE tissues from patients with geographic atrophy and aged mice, laser-induced subretinal fibrosis, and primary human RPE cells. Human RPE was examined by TUNEL staining, reactive oxygen species generation, cell viability, and senescence-associated β-galactosidase staining. RESULTS: The volume of subretinal fibrosis was significantly smaller in cavtratin-injected eyes from wild-type mice than in control eyes from wild-type, P = 0.0062, and Cav-1-/- mice, P = 0.0095. Cavtratin treatment produced significant improvements in primary RPE cell contraction in wild-type, P = 0.04, and Cav-1-/- mice, P = 0.01. p16INK4a expression in the RPE was higher in patients with than without geographic atrophy. p16INK4a was expressed in 18-month-old but not 2-month-old wild-type mouse eyes. p16INK4a and collagen type I antibodies showed co-localization in subretinal fibrosis. Cavtratin did not affect RPE cell apoptosis or reactive oxygen species generation, but decreased cell viability and increased senescence-associated β-galactosidase-positive cells. CONCLUSIONS: Enhanced expression of caveolin-1 successfully blocked epithelial-mesenchymal transition of RPE and the reduction of subretinal fibrosis in mice. Nevertheless, in exchange for blocking subretinal fibrosis, caveolin-1 promotes RPE cellular senescence and might affect the progression of geographic atrophy in AMD.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Shimizu H, Yamada K, Suzumura A, et al. Caveolin-1 Promotes Cellular Senescence in Exchange for Blocking Subretinal Fibrosis in Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2020. PMID: 32926104. doi:10.1167/iovs.61.11.21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。